ʻO Alpheus ™ Medical, Inc, kahi hui pilikino e hoʻomohala ana i kahi papa sonodynamic therapy (SDT) e kuhikuhi ana i nā maʻi maʻi maʻi kino paʻa, i kēia lā ua hoʻolaha i ka hoʻokumu ʻana o kā lākou Scientific Advisory Board (SAB) me ke koho ʻana i nā loea alakaʻi o ka honua i ka ʻoihana neuro- oncology, neurosurgery, chemistry, and molecular biology. ʻO nā lālā hoʻokumu o ka SAB e komo pū me Dr. Roger Stupp (Northwestern University Feinberg School of Medicine), Dr. David Reardon (Harvard Medical School a me Dana-Farber Cancer Institute), Dr. Walter Stummer (University Hospital Münster, Germany), a me Dr. Mathias Senge (Trinity College Dublin, Ireland).
"Haʻaheo mākou i ka hoʻolaha ʻana i nā alakaʻi manaʻo nui o ka honua i ka glioblastoma ma ke ʻano he ʻāpana o kā mākou papa aʻoaʻo ʻepekema," wahi a Vijay Agarwal, MD, Luna Nui o Alpheus Medical. "Me kēia pūʻulu hanohano, ua mākaukau mākou e hoʻomau i kā mākou holomua i ke kaua kūʻē i ka maʻi maʻi lolo i ʻike i ka nui o nā hemahema a me nā mea hou therapeutic liʻiliʻi i nā makahiki he mau makahiki. ʻO nā hana lapaʻau a me ke alakaʻi ʻana o kēia SAB mua i hui pū ʻia me kā mākou $16M Series A hōʻaiʻē kālā e lilo i mea kōkua i ka wā e hoʻomaka ai mākou i kā mākou FIH hoʻokolokolo a e ʻimi i nā hōʻoia o nā haʻawina manaʻo no nā maʻi maʻi maʻi maʻi paʻa.
ʻO Alpheus Medical's proprietary, investigational SDT treatment is a innovative, non-invasive drug-device hui e hoʻopaʻa ana i nā maʻi maʻi maʻi maʻi ma ka hemisphere holoʻokoʻa me ka haʻahaʻa haʻahaʻa, nui kahua ultrasound. Hana ʻia ka lāʻau lapaʻau ma kahi hoʻonohonoho outpatient, hiki ke hana hou ʻia, ʻaʻole pono e hoʻohana i ke kiʻi, e like me MRI.
"ʻOliʻoli wau e alakaʻi i kēia hui o nā kauka lapaʻau kūikawā a me nā mea noiʻi i ka wā e hoʻomaka ai mākou e kākau inoa i ka hoʻokolokolo mua-i-kanaka i nā mahina e hiki mai ana," wahi a Roger Stupp, MD, ka luna o ka Alpheus Medical SAB, Co-Director o ka Malnati. ʻO Brain Tumor Institute o ka Lurie Comprehensive Cancer Center, a me ke poʻo o Neuro-Oncology ma ke kula ʻo Feinberg School of Medicine o Northwestern University. "Ma ke koho koho ʻana a me ka pepehi ʻana i nā maʻi maʻi maʻi ma waena o ka hemisphere holoʻokoʻa me SDT, ʻoi aku ka maikaʻi o ke ala ʻana o Alpheus a hiki ke hoʻololi i ke ʻano o kā mākou mālama ʻana i nā mea maʻi me ka glioblastoma hou."
He aha e lawe ʻia mai kēia ʻatikala:
- ʻO nā hana lapaʻau a me ke alakaʻi ʻana o kēia SAB mua i hui pū me kā mākou $16M Series A hōʻaiʻē kālā e lilo i mea kōkua i ka wā e hoʻomaka ai mākou i kā mākou hoʻokolokolo FIH a e ʻimi i nā hōʻoia o nā haʻawina manaʻo no nā maʻi maʻi maʻi maʻi paʻa.
- ʻO Alpheus ™ Medical, Inc, kahi hui pilikino e hoʻomohala ana i kahi papa sonodynamic therapy (SDT) e kuhikuhi ana i nā maʻi maʻi kino paʻa, i kēia lā ua hoʻolaha i ka hoʻokumu ʻana o kā lākou Scientific Advisory Board (SAB) me ke koho ʻana i nā poʻe loea alakaʻi o ka honua i ka ʻoihana neuro- oncology, neurosurgery, chemistry, and molecular biology.
- Ua ʻōlelo ʻo Roger Stupp, MD, Luna Hoʻomalu o ka Alpheus Medical SAB, Co-Director o ka Malnati Brain Tumor Institute o ka Lurie Comprehensive Cancer Center, a me ke poʻo o ka Neuro-Oncology ma Northwestern University's Feinberg School of Medicine.
